The spatial contrast sensitivity function and its neurophysiological bases.

Contrast sensitivity function Magnocellular/parvocellular pathways Spatial frequency Transient/sustained mechanisms Visual receptive field difference of Gaussians model

Journal

Vision research
ISSN: 1878-5646
Titre abrégé: Vision Res
Pays: England
ID NLM: 0417402

Informations de publication

Date de publication:
09 2023
Historique:
received: 06 02 2023
revised: 02 05 2023
accepted: 14 05 2023
pmc-release: 01 09 2024
medline: 17 7 2023
pubmed: 30 5 2023
entrez: 29 5 2023
Statut: ppublish

Résumé

Contrast processing is a fundamental function of the visual system, and contrast sensitivity as a function of spatial frequency (CSF) provides critical information about the integrity of the system. Here, we used a novel iPad-based instrument to collect CSFs and fitted the data with a difference of Gaussians model to investigate the neurophysiological bases of the spatial CSF. The reliability of repeat testing within and across sessions was evaluated in a sample of 22 adults for five spatial frequencies (0.41-13 cycles/degree) and two temporal durations (33 and 500 ms). Results demonstrate that the shape of the CSF, lowpass versus bandpass, depends on the temporal stimulus condition. Comparisons with previous psychophysical studies and with single-cell data from macaques and humans indicate that the major portion of the CSF, spatial frequencies >1.5 cycles/degree regardless of temporal condition, is determined by a 'sustained' mechanism (presumably parvocellular input to primary visual cortex [V1]). Contrast sensitivity to the lowest spatial frequency tested appears to be generated by a 'transient' mechanism (presumably magnocellular input to V1). The model fits support the hypothesis that the high spatial frequency limb of the CSF reflects the receptive field profile of the center mechanism of the smallest cells in the parvocellular pathway. These findings enhance the value of contrast sensitivity testing in general and increase the accessibility of this technique for use by clinicians through implementation on a commercially-available device.

Identifiants

pubmed: 37247511
pii: S0042-6989(23)00090-1
doi: 10.1016/j.visres.2023.108266
pmc: PMC10527080
mid: NIHMS1906481
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108266

Subventions

Organisme : NIMH NIH HHS
ID : R33 MH115119
Pays : United States
Organisme : NIMH NIH HHS
ID : R61 MH115119
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Eur J Neurosci. 2021 Feb;53(4):1155-1170
pubmed: 33118212
J Opt Soc Am. 1972 Mar;62(3):446-8
pubmed: 5059979
Vision Res. 1972 May;12(5):825-33
pubmed: 5037705
J Vis. 2010 Mar 30;10(3):17.1-21
pubmed: 20377294
Science. 1980 Sep 12;209(4462):1255-6
pubmed: 7403884
J Neurophysiol. 1953 Jan;16(1):37-68
pubmed: 13035466
Sci Rep. 2017 Apr 21;7:46706
pubmed: 28429773
J Physiol. 1965 Dec;181(3):576-93
pubmed: 5880378
J Gen Physiol. 1957 Jan 20;40(3):357-76
pubmed: 13398569
Vision Res. 2013 Sep 20;90:10-4
pubmed: 23643905
Neurotoxicol Teratol. 2006 Sep-Oct;28(5):573-88
pubmed: 17010568
J Opt Soc Am. 1980 Sep;70(9):1121-6
pubmed: 7411270
Vision Res. 1972 Jan;12(1):89-101
pubmed: 5034636
J Physiol. 1968 Aug;197(3):551-66
pubmed: 5666169
J Vis. 2018 Nov 1;18(12):7
pubmed: 30452585
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4811-4
pubmed: 11287663
J Neurosci. 1991 Nov;11(11):3422-9
pubmed: 1941091
Vision Res. 2003 Sep;43(20):2133-9
pubmed: 12855249
Vis Neurosci. 1988;1(1):145-50
pubmed: 3154786
Ann Neurol. 1991 Jan;29(1):41-52
pubmed: 1996878
J Opt Soc Am. 1961 Jul;51:740-6
pubmed: 13763863
J Gen Physiol. 1956 May 20;39(5):651-73
pubmed: 13319654
J Vis. 2020 Dec 2;20(13):17
pubmed: 33369613
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):198-207
pubmed: 26795826
J Opt Soc Am. 1956 Sep;46(9):721-39
pubmed: 13358013
J Physiol. 1975 Sep;251(1):167-95
pubmed: 810576
Brain. 1977 Sep;100(3):563-79
pubmed: 589432
Vision Res. 1995 Jan;35(1):7-24
pubmed: 7839612
J Gen Physiol. 1942 Jul 20;25(6):819-40
pubmed: 19873316
J Acoust Soc Am. 1971 Feb;49(2):Suppl 2:467+
pubmed: 5541744
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
J Cataract Refract Surg. 1989 Mar;15(2):141-8
pubmed: 2724114
Br J Math Stat Psychol. 1965 May;18:1-10
pubmed: 14324842
J Physiol. 1973 Jul;232(1):149-62
pubmed: 4733479
Vision Res. 1978;18(1):69-81
pubmed: 664278
Vision Res. 1980;20(5):443-52
pubmed: 7414979
J Neurosci. 1993 Dec;13(12):5334-55
pubmed: 8254378
Invest Ophthalmol Vis Sci. 1984 Nov;25(11):1307-15
pubmed: 6490332
Invest Ophthalmol Vis Sci. 2013 Nov 05;54(12):7266-73
pubmed: 24114545
Vis Neurosci. 1990 Jan;4(1):75-93
pubmed: 2176096
J Physiol. 1966 Dec;187(3):517-52
pubmed: 16783910
Behav Brain Res. 1983 Oct;10(1):87-97
pubmed: 6639735
Vision Res. 1986;26(11):1751-61
pubmed: 3617516
J Opt Soc Am. 1966 May;56(5):689-94
pubmed: 5963523
Vision Res. 1979;19(1):19-32
pubmed: 419698
Am J Psychol. 1962 Sep;75:485-91
pubmed: 13881416
Vision Res. 1977;17(7):861-5
pubmed: 898692
J Vis. 2016;16(6):18
pubmed: 27120074
J Physiol. 1975 Aug;249(3):519-48
pubmed: 1177103
Vision Res. 2023 Jan;202:108154
pubmed: 36436365
J Neurosci. 1988 May;8(5):1594-609
pubmed: 3367212
Vision Res. 1976;16(6):567-72
pubmed: 960578
Annu Rev Neurosci. 1993;16:369-402
pubmed: 8460898
Science. 1972 Nov 17;178(4062):769-71
pubmed: 5082844
J Optom. 2015 Apr-Jun;8(2):101-8
pubmed: 25890826
J Opt Soc Am A. 1990 Dec;7(12):2223-36
pubmed: 2090801
Vision Res. 1981;21(7):971-83
pubmed: 7314501
Transl Vis Sci Technol. 2018 Nov 14;7(6):9
pubmed: 30479880
Vision Res. 1965 Dec;5(11):583-601
pubmed: 5862581
Brain. 1987 Dec;110 ( Pt 6):1675-98
pubmed: 3427405
J Neurosci. 1991 Apr;11(4):994-1001
pubmed: 2010820
Biol Sex Differ. 2012 Sep 04;3(1):20
pubmed: 22943466
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9666-70
pubmed: 1409680

Auteurs

Vance Zemon (V)

Ferkauf Graduate School of Psychology, Yeshiva University, 1165 Morris Park Ave., Bronx, NY 10461, USA; Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd., Orangeburg, NY 10962, USA. Electronic address: vepman@aol.com.

Pamela D Butler (PD)

Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd., Orangeburg, NY 10962, USA; Department of Psychiatry, New York University School of Medicine, One Park Ave, New York, NY 10016, USA. Electronic address: pam.butler@nki.rfmh.org.

Michael E Legatt (ME)

Resilient Grid, 7000 Mopac Expy, Suite #200, Austin, TX 78731. Electronic address: legatt@resilientgrid.com.

James Gordon (J)

Department of Psychology, Hunter College, City University of New York, 695 Park Ave., New York, NY 10065, USA. Electronic address: jgordon@hunter.cuny.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH